summary: The effect of statins, usually used for reducing cholesterol, is under ongoing investigation in MS. The authors looked at combination treatment with interferon beta 1b and atorvastatin in people with relapsing-remitting MS. They found that people who took both medications had lower levels of a protein involved in inflammation. However, whether this is of any clinical benefit is still unclear.

authors: Sellner J, Greeve I, Mattle HP.

source: Mult Scler. 2008 Jun 23. [Epub ahead of print]

weblink: click here

category: Clinical Trials and Therapeutics

related research news: click here

glossary: